Treating HFrEF: Is Clinical Practice the Same Around the World?
Published: 20 November 2020
-
Views:
203
-
Likes:
7
-
Views:
203
-
Likes:
7
-
8m 58sPart 3 Panel Discussion
-
18m 18sPart 1 Treating HFrEF in the Americas: Best Practices and Improvement Opportunities Justin Ezekowitz
Overview
In this Satellite Symposium from the e-SPACE Heart Failure Global Web-Conference, Stefan Anker, John JV McMurray, Justin Ezekowitz, Piotr Ponikowski and Carolyn Lam discuss the clinical practices for treating HFrEF around the world.
Learning Objectives
- Understanding Global Challenges in Clinical Practice to Achieving Guideline–Directed Medical Therapy (GDMT) for HFrEF Patients Across the Globe Including Underrepresented and Minority Populations
- Identify Similarities and Common Residual Risk Patterns Despite Regional Guidelines and Local Clinical Practice
- Evaluate Regional Unmet Needs, Advancements in Management, and Share Regional Best Practice to Achieving GDMT
- Discussion on Fundamental Pathways of HFrEF Pathophysiology and Progression
Agenda
- Treating HFrEF in the Americas: Best Practices and Improvement Opportunities (Justin Ezekowitz)
- Are Challenges to Achieving Guideline-Directed Medical Therapy Different in Europe? (Piotr Ponikowski)
- Panel Discussion (Stefan Anker, Carolyn Lam, John McMurray, Justin Ezekowitz & Piotr Ponikowski)
More from this programme
Part 1
Treating HFrEF in the Americas: Best Practices and Improvement Opportunities
Part 2
Are Challenges to Achieving Guideline-Directed Medical Therapy Different in Europe?
Part 3
Panel Discussion
| 1 session | |
| Panel Discussion | Watch now |
Faculty Biographies
Piotr Ponikowski
Head of the Department of Heart Diseases
Piotr Ponikowski is Head of the Department of Heart Diseases, Wroclaw Medical University and Head of the Cardiology Department at the Center for Heart Diseases at 4th Military Hospital, Wroclaw, Poland. His research interests mainly include heart failure (HF), coronary artery disease and cardiac arrhythmias. He has been involved in numerous research projects, such as the benefits of physical rehabilitation in patients with chronic HF, assessment of metabolic derangements in HF (with special interest in iron deficiency), evaluation of reflex control in the cardiorespiratory system in order to optimise assessment and management of patients with HF. He has been involved in numerous clinical trials as main investigator, member of international steering committees, endpoint committees and advisory boards.